The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy.

Huub J PoelmanRoger C W Wolfs Wishal D Ramdas

Published in: Clinical ophthalmology (Auckland, N.Z.) (2020)

The efficacy of the Baerveldt implant is a significant reduction in IOP in the long term. The safety profile of the Baerveldt implant in terms of complication incidence is similar to those reported for other GDD's. For treatment of secondary glaucoma, we suggest the Baerveldt (or any other similar GDD) as the choice of treatment in patients where highest IOP reduction is desired.

Keyphrases

soft tissue
optic nerve
risk factors
stem cells
replacement therapy